Concepedia

Kurt Jarnagin

KJ

Statistics

Publications

48

Citations

5K

H-Index

31

Active since

1983

Affiliations

Roche (United States)(Current)

Johannes Gutenberg University Mainz

University of California, San Francisco

Epix Pharmaceuticals (United States)

Roche (Switzerland)

Kurt Jarnagin is an author at Roche (United States) specializing in pharmacology, life sciences, and medicine.

Publications per year

1983–2024

48

Publications

48

The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling

Yousuke Ebina, Leland Ellis, Kurt Jarnagin et al. · Cell · 1985 · 1.5K citations

, , +15

Expression cloning of a rat B2 bradykinin receptor.

Adrienne E. McEachern, Earl R. Shelton, Sunil Bhakta et al. · Proceedings of the National Academy of Sciences · 1991 · 428 citations · Full text

, , +15

Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action

Brigitte Ganter, Stuart Tugendreich, Cecelia I. Pearson et al. · Journal of Biotechnology · 2005 · 287 citations

, , +16

Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor Antagonists

Tara Mirzadegan, Frank Diehl, Bettina Ebi et al. · Journal of Biological Chemistry · 2000 · 249 citations · Full text

, , +17

Monomeric Monocyte Chemoattractant Protein-1 (MCP-1) Binds and Activates the MCP-1 Receptor CCR2B

Chad D. Paavola, Stefan Hemmerich, D. Grünberger et al. · Journal of Biological Chemistry · 1998 · 199 citations · Full text

, , +14

1–5 of 48